.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09D_AngiotensinIiReceptorBlockersArbsCombinations.C09DB02_OlmesartanMedoxomilAndAm.OlmesartanMedoxomilAndAm .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09D_AngiotensinIiReceptorBlockersArbsCombinations.C09DB02_OlmesartanMedoxomilAndAm.OlmesartanMedoxomilAndAm| name: | OlmesartanMedoxomilAndAmlodipine | |
| ATC code: | C09DB02 | route: | oral |
| compartments: | 2 | |
| dosage: | 20 | mg |
| volume of distribution: | 17 | L |
| clearance: | 1.3 | L/h |
| other parameters in model implementation | ||
Olmesartan medoxomil is an angiotensin II receptor antagonist (ARB) and amlodipine is a dihydropyridine calcium channel blocker. Co-formulated as a fixed-dose combination, this medication is used for treating hypertension (high blood pressure) in adults and children over 6 years. It is approved for current clinical use in many countries to help lower risk of cardiovascular events by controlling blood pressure.
Pharmacokinetic parameters for healthy adult volunteers after oral administration of the combination tablet. PK values are reported separately for olmesartan and amlodipine.